Patents/Assignees

AMGEN Inc.

354 patents in portfolio

US11897963utility2024
Anti-jagged1 Antigen Binding Proteins
0 cites
US11897965utility2024
Anti-jagged1 Antigen Binding Proteins
0 cites
US11900540utility2024
3D Particle Imaging in Pharmaceutical Containers
0 cites
US11891435utility2024
Polynucleotides Encoding Monoclonal Antibodies Binding to Human Pituitary Adenylate Cyclase-activating Polypeptide Type I Receptor (PAC1) and Methods of Making Thereof
0 cites
US11890450utility2024
Backflow Prevention Mechanism for Drug Delivery Device
0 cites
US11884720utility2024
Antibody Constructs for MSLN and CD3
0 cites
US11887302utility2024
Systems and Methods for Detecting Cytopathic Effect in Cells
0 cites
US11878149utility2024
Drug Delivery Device
0 cites
US11873343utility2024
Pharmaceutical Formulations Comprising Anti-rankl Antibodies and an Aromatic Amino Acid Comprising a Phenyl or an Indole
0 cites
US11874233utility2024
Sheet Lighting for Particle Detection in Drug Product Containers
0 cites
US11873344utility2024
Protein Biomarker and Uses Thereof
0 cites
US11872282utility2024
Treatment of Ovarian Cancer in Patients with Ascites Using a Specific Binding Agent of Human Angiopoietin-2 in Combination with a Taxane
0 cites
US11872374utility2024
Drug Delivery Device Having a Needle Guard Mechanism with a Tunable Threshold of Resistance to Needle Guard Movement
0 cites
USD1010811design2024
Handheld Drug Delivery Device
0 cites
US11866508utility2024
Anti-mesothelin Binding Proteins
0 cites
USD1010107design2024
Handheld Drug Delivery Device
0 cites
US11858983utility2024
C-terminal Anti-sclerostin Antibody Variants
0 cites
US11854779utility2023
Systems and Methods for Reducing Lab-to-lab And/or Instrument-to-instrument Variability of Multi-attribute Method (MAM) by Run-time Signal
0 cites
US11854781utility2023
Electrophoretic Mass Spectrometry Probes and Systems and Uses Thereof
0 cites
US11845760utility2023
PRMT5 Inhibitors
0 cites

← PreviousPage 14 of 18Next →